arbekacin has been researched along with aranorosin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanaki, H; Ishii, T; Iwatsuki, M; Masuma, R; Matsui, H; Nonaka, K; Omura, S; Shiomi, K; Suga, T; Yamamoto, T | 1 |
1 other study(ies) available for arbekacin and aranorosin
Article | Year |
---|---|
Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6')/APH(2″).
Topics: Acetyltransferases; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Enzyme Inhibitors; Furans; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Phosphotransferases (Alcohol Group Acceptor) | 2012 |